For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Sodium Ferric Gluconate | Sodium ferric gluconate 250 mg administered intravenously every 12 hours until iron repletion completed (as determined by Ganzoni equation) or patient discharge, whichever comes first. | None | None | 1 | 13 | 11 | 13 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| Clinical Deterioration | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| nausea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| constipation | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| diarrhea | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| injection site itching | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| injection site discomfort | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| thrombophlebitis | NON_SYSTEMATIC_ASSESSMENT | Vascular disorders | None | View |
| cellulitis | NON_SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | None | View |
| headache | NON_SYSTEMATIC_ASSESSMENT | Nervous system disorders | None | View |
| dyspnea | NON_SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | None | View |
| back pain | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| leg cramps | NON_SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | None | View |
| bladder discomfort | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| fatigue | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| chills | NON_SYSTEMATIC_ASSESSMENT | General disorders | None | View |
| melena | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |
| hematuria | NON_SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | None | View |
| abdominal discomfort | NON_SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | None | View |